Locations:
SearchAdvertisement
New findings could shape the treatment paradigm for a select group of bladder cancer patients
Patients with genetic mutation need more than ocular treatment
Should institutions adopt “time to treatment” as a new quality metric?
A multidisciplinary team of Cleveland Clinic scientists looks to evolution for answers
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Decision-making models improve Black patients' understanding of screening protocols
Drug beats standard care for the treatment of relapsed or refractory ALL
APE2 may hold the key to reducing cisplatin toxicity
Endoluminal surgery provides new treatment options
Pairing low-frequency ultrasound with microbubble resonators to penetrate the blood-brain barrier
Slight deviation from treatment paradigm salvages significant anatomy
Advertisement
Advertisement